ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,054,602 | -11.9% | 278,959 | +6.5% | 0.00% | 0.0% |
Q2 2023 | $3,467,145 | -2.8% | 261,869 | -0.0% | 0.00% | 0.0% |
Q1 2023 | $3,565,207 | -33.5% | 261,955 | -4.5% | 0.00% | 0.0% |
Q4 2022 | $5,358,505 | +31.2% | 274,373 | +28.0% | 0.00% | 0.0% |
Q3 2022 | $4,083,000 | +9.8% | 214,291 | +18.7% | 0.00% | 0.0% |
Q2 2022 | $3,718,000 | -38.1% | 180,511 | -3.4% | 0.00% | 0.0% |
Q1 2022 | $6,011,000 | +25.8% | 186,800 | +82.0% | 0.00% | 0.0% |
Q4 2021 | $4,777,000 | +147.6% | 102,614 | +43.6% | 0.00% | – |
Q3 2021 | $1,929,000 | +29.4% | 71,460 | +22.9% | 0.00% | – |
Q2 2021 | $1,491,000 | -20.9% | 58,130 | +5.5% | 0.00% | – |
Q1 2021 | $1,884,000 | +35.0% | 55,111 | +33.6% | 0.00% | – |
Q4 2020 | $1,396,000 | +94.4% | 41,260 | +41.9% | 0.00% | – |
Q3 2020 | $718,000 | – | 29,069 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |